Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Eisai
Payers
CMS is removing PET scan restrictions for Alzheimer's patients
After CMS floated the idea in July, the agency decided to remove restrictions for brain scans, helping patients receive access to drugs like Leqembi.
Noah Tong
Oct 13, 2023 3:35pm
Broader Leqembi coverage could burden Medicare, critics warn
Jul 17, 2023 12:02pm
CMS won’t cover lecanemab without more proof of its effectiveness
Mar 14, 2023 5:00pm
Biden touts Part B cuts amid promising Alzheimer's study data
Sep 28, 2022 4:35pm
